Skip to main navigation Skip to search Skip to main content

Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives as selective inhibitors of EGFR threonine790 to methionine790 (T790M) mutants

  • Tianfeng Xu
  • , Lianwen Zhang
  • , Shilin Xu
  • , Chao Yie Yang
  • , Jinfeng Luo
  • , Fang Ding
  • , Xiaoyun Lu
  • , Yingxue Liu
  • , Zhengchao Tu
  • , Shiliang Li
  • , Duanqing Pei
  • , Qian Cai
  • , Honglin Li
  • , Xiaomei Ren
  • , Shaomeng Wang
  • , Ke Ding*
  • *Corresponding author for this work
  • CAS - Guangzhou Institute of Biomedicine and Health
  • University of Chinese Academy of Sciences
  • University of Michigan, Ann Arbor
  • East China University of Science and Technology

Research output: Contribution to journal › Article › peer-review

Abstract

Catching the mutants: Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives (see example) were identified as specific inhibitors of EGFRT790M mutants. The compounds bound with T790M or L858R/T790M mutants with significantly lower Kd values than that with EGFRWT. They also selectively inhibited EGFR signal transduction and proliferation of NSCLC cells harboring EGFRL858R/T790M mutation, but were significantly less potent to cells with EGFRWT.

Original languageEnglish
Pages (from-to)8387-8390
Number of pages4
JournalAngewandte Chemie - International Edition
Volume52
Issue number32
DOIs
StatePublished - 5 Aug 2013
Externally publishedYes

Keywords

  • T790M mutants
  • drug design
  • inhibitors
  • selectivity

Fingerprint

Dive into the research topics of 'Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives as selective inhibitors of EGFR threonine790 to methionine790 (T790M) mutants'. Together they form a unique fingerprint.

Cite this